Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |